Mechanism of action, potency and efficacy: considerations for cell therapies
2024 · Journal of Translational Medicine · 11 citations
https://doi.org/10.1186/s12967-024-05179-7
S
Sandrine Vessillier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
724
Citations
15
h-index
22
i10-index
Sandrine Vessillier is an academic researcher from European Medicines Agency. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research & Virus-based gene therapy research. The author has an h-index of 15, co-authored 40 publications.
ORCID: 0000-0002-9697-1834Papers by this author
worksLow oxygen tension increased fibronectin fragment induced catabolic activities - response prevented with biomechanical signals
2013 · Arthritis Research & Therapy · 7 citations
https://doi.org/10.1186/ar4346
C-type natriuretic peptide signalling drives homeostatic effects in human chondrocytes
2015 · Biochemical and Biophysical Research Communications · 5 citations
https://doi.org/10.1016/j.bbrc.2015.08.087
Additional file 1 of Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy products
2025 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.28537978
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat